Liraglutide, sold under the brand names Victoza and Saxenda among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity...
31 KB (2,666 words) - 11:03, 12 June 2024
Insulin degludec/liraglutide, sold under the brand name Xultophy, is a fixed-dose combination medication for the treatment of adults with type 2 diabetes...
7 KB (479 words) - 11:42, 6 August 2024
at Novo Nordisk led by the scientist Lotte Bjerre Knudsen developed liraglutide, a glucagon-like peptide-1 receptor agonist that could be used to treat...
66 KB (5,434 words) - 17:03, 8 August 2024
dose compared to liraglutide in some of the measured parameters after ten weeks of daily intraperitoneal injections with liraglutide (2.5 or 25 nmol/kg)...
21 KB (1,930 words) - 06:59, 1 July 2024
Danish scientist and university professor. She led the development of liraglutide and semaglutide,[third-party source needed] two notable drugs approved...
15 KB (1,637 words) - 22:56, 4 July 2024
blood. With the exception of insulin, most GLP-1 receptor agonists (liraglutide, exenatide, and others), and pramlintide, all diabetes medications are...
50 KB (5,222 words) - 01:54, 18 August 2024
diabetes GLP-1 receptor agonists : albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, tirzepatide and semaglutide, the latter of which is marketed...
26 KB (3,386 words) - 20:19, 8 August 2024
been studied, showing improvements in biochemistry and colonic transit. Liraglutide, a GLP-1 receptor agonist had unexpected effects in clinical cases with...
23 KB (2,679 words) - 09:31, 21 July 2024
GLP-1 receptor agonists became popular for weight loss. The medications liraglutide, naltrexone/bupropion, orlistat, semaglutide, and tirzepatide are approved...
53 KB (4,991 words) - 05:08, 21 July 2024
S2CID 73313508. "Lilly's Once-Weekly Dulaglutide Shows Non-Inferiority to Liraglutide in Head-to-Head Phase III Trial for Type 2 Diabetes" (Press release)...
16 KB (1,511 words) - 23:59, 19 July 2024